← Back to Search

Behavioural Intervention

Internet-Based App for Breast Cancer Treatment Adherence

Atlanta, GA

N/A

Recruiting

Led By Deepthi Kodali, MBBS

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age >= 18

Early-stage hormone receptor positive, HER2-negative breast cancer who have completed all recommended (neo)adjuvant chemotherapy, surgery and/or radiation therapy

Must not have

Patients who are HER2 neu positive

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 1 year

Awards & highlights

No Placebo-Only Group

Summary

This trial is looking at whether an internet-based app can help improve adherence to a cancer treatment regimen.

See full description

Who is the study for?

This trial is for adults over 18 with early-stage hormone receptor-positive, HER2-negative breast cancer who've finished recommended treatments and started on aromatase inhibitors or Tamoxifen within the last six months. Participants need internet access and must speak English.Check my eligibility

What is being tested?

The study tests a web-based app designed to help patients stick to their endocrine therapy. It includes features like medication reminders, educational videos about side effect management, and direct contact with healthcare providers.See study design

What are the potential side effects?

While not directly related to the app intervention being tested, endocrine therapy can cause joint pain, hot flashes, fatigue, mood changes, and decreased bone density among other potential side effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

show original

Select...

I have early-stage, hormone receptor positive, HER2-negative breast cancer and have completed all recommended treatments.

show original

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

My cancer is HER2 positive.

show original

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Feasibility (Acceptability)

Feasibility (Compliance)

Secondary study objectives

Adherence

Patient satisfaction

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Single Arm (internet intervention, best practice)Experimental Treatment4 Interventions

Patients receive access to the app in addition to standard of care for 3 months. Through the app, patients receive weekly reminders about hormone therapy, report any side effects, access educational videos that provide tips to help mitigate some of these side effects, and allow patients to send messages to members of our breast cancer team about any questions patients may have about the side effects they may be experiencing.

0 / 3Eligibility criteria met